Hadani, Samera S.

HRN: 18-89-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2022
CEFUROXIME 750MG (VIAL)
05/24/2022
05/31/2022
IVT
750mg
Q8
UTI
05/24/2022
CEFTRIAXONE 1G (VIAL)
05/24/2022
05/24/2022
IVT
1g
LD
OR
Waiting Final Action 
05/25/2022
CEFUROXIME 500MG (TAB)
05/25/2022
05/31/2022
ORAL
500mg
Q12
S/P Exlap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: